Dry powder inhaler
ADVANCEMENTS IN DRY POWDER INHALER
5
Recent advances in capsule-based dry powder inhaler technology
7
Bronchodilator Response to Salbutamol Delivered by Metered Dose Inhaler with Spacer and Dry Powder Inhaler in Acute Asthma In Children: A Comparative Study
6
Comparative Analysis of Metered Dose Inhaler (MDI) and Dry Powder Inhaler (DPI) at Rural Bangladesh Perspective
5
Profile of fluticasone furoate/vilanterol dry powder inhaler combination therapy as a potential treatment for COPD
8
Development and Validation of Analytical Method for Simultaneous Estimation of Formoterol Fumarate Dihydrate and Fluticasone Propionate from Bulk and Dry Powder Inhaler Formulation
11
Nanosized rods agglomerates as a new approach for formulation of a dry powder inhaler
10
PAST AND PRESENT TRENDS OF DRY POWDER INHALER DEVICES: A REVIEW
11
“Pharmacokinetic Study of Dry Powder Inhaler Formulations of Antiasthmatic Drugs” by Dhara P. Jain, Parag Vijay Jain, M. R. Bhalekar, India.
9
Evaluation of systemic absorption and bronchodilator effect of glycopyrronium bromide delivered by nebulizer or a dry powder inhaler in subjects with chronic obstructive pulmonary disease
12
A RAPID AND STABILITY INDICATING RP HPLC METHOD FOR SIMULTANEOUS DETERMINATION OF TIOTROPIUM, FORMOTEROL AND CICLESONIDE IN A DRY POWDER INHALER
12
DRY POWDER INHALER; SPECIAL EMPHASIS TO FORMULATION, DEVICES, CHARACTERIZATION & PROCESS VALIDATION PROTOCOL: A REVIEW
5
Improved adherence with once-daily versus twice-daily dosing of mometasone furoate administered via a dry powder inhaler: a randomized open-label study
9
PREPARATION AND CHARECTERIZATION OF PRONIOSOMAL DRY POWDER INHALER OF BUDESONIDE USING LACTOSE CARRIER FOR NASAL ADMINISTRATION
19
Dose–response of an extrafine dry powder inhaler formulation of glycopyrronium bromide: randomized, double-blind, placebo-controlled, dose-ranging study (GlycoNEXT)
11
Patient preferences for dry powder inhaler attributes in asthma and chronic obstructive pulmonary disease in France: a discrete choice experiment
11
Ease-of-use preference for the ELLIPTA<sup>®</sup> dry powder inhaler over a commonly used single-dose capsule dry powder inhaler by inhalation device-naïve Japanese volunteers aged 40 years or older
11
Qualitative assessment of attributes and ease of use of the ELLIPTA™ dry powder inhaler for delivery of maintenance therapy for asthma and COPD
14
Inspiratory flows through dry powder inhaler in chronic obstructive pulmonary disease: age and gender rather than severity matters
6
Long-term safety of Mometasone Furoate administered via a dry powder inhaler in children: Results of an open-label study comparing Mometasone Furoate with Beclomethasone Dipropionate in children with persistent asthma
7